Colgate-Palmolive Company

(New York Stock Exchange)
Slightly Bullish +15

Corient Private Wealth LLC Buys 64,926 Shares of Colgate-Palmolive ...

πŸ“ˆ Corient Private Wealth LLC increased its CL stake by 13.6% in Q4, adding 64,926 shares for a total holding of 541,110 shares valued at $42.789 million.

🏦 Teacher Retirement System of Texas boosted its position by 35.3%, now owning 469,624 shares worth $37.11 million after buying 122,634 additional shares.

πŸ“‰ Citigroup Inc. grew its CL holdings by 43.7% in Q3, accumulating 1,346,590 shares valued at $107.646 million.

πŸš€ GAMMA Investing LLC raised its stake by 114.2% to own 23,329 shares worth $1.843 million during the fourth quarter.

πŸ“Š Grantham Mayo Van Otterloo & Co. LLC increased its position by 217.0% in Q3, holding 40,605 shares valued at $3.246 million.

πŸ’° Avior Wealth Management initiated a new position in Colgate-Palmolive valued at approximately $1.135 million in the fourth quarter.

πŸ“ˆ Institutional ownership of Colgate-Palmolive stands at 80.41% as of the latest filings.

πŸ’΅ The company declared a quarterly dividend of $0.53 per share, payable on August 14th to shareholders of record on July 20th.

πŸ“‰ The stock has a market cap of $71.81 billion with a P/E ratio of 34.92 and a beta of 0.33.

πŸ“Š Barclays raised its price target from $79 to $80 while maintaining an equal weight rating on the stock.

πŸ“‰ Wells Fargo cut its price target from $100 to $92 but retained an equal weight rating on CL shares.

πŸ“‰ Piper Sandler lowered its price target from $96 to $92 and upgraded the rating to overweight.

Bullish Signals
  • Corient Private Wealth LLC increased its investment in Colgate-Palmolive by 13.6% in Q4, signaling continued institutional confidence.
  • Teacher Retirement System of Texas significantly boosted its stake by 35.3%, adding over 122,000 shares to its portfolio.
  • Citigroup Inc. grew its position by 43.7% in the third quarter, accumulating a substantial holding of over 1.3 million shares.
  • GAMMA Investing LLC raised its stake by 114.2%, demonstrating strong interest from this major investment firm.
  • Grantham Mayo Van Otterloo & Co. LLC increased its position by 217.0% in Q3, indicating a bullish view on the stock.
  • Avior Wealth Management initiated a new long position valued at $1.135 million, entering the market as a new holder.
  • Barclays raised its price target from $79 to $80, reflecting a positive adjustment in valuation expectations.
Risk Factors
  • Wells Fargo & Company reduced its price target from $100.00 to $92.00, indicating some analysts see limited upside at current levels.
  • Piper Sandler cut its price target from $96.00 to $92.00, suggesting a more conservative valuation outlook for the stock.
Full Analysis
Corient Private Wealth LLC increased its stake in Colgate-Palmolive Company (NYSE:CL) by 13.6% during the fourth quarter, purchasing an additional 64,926 shares to hold a total of 541,110 shares valued at $42.789 million. Several other institutional investors also adjusted their positions, including Teacher Retirement System of Texas boosting its stake by 35.3% and Citigroup Inc. growing its position by 43.7%. GAMMA Investing LLC and Grantham Mayo Van Otterloo & Co. LLC significantly raised their stakes, while Avior Wealth Management initiated a new position. The article details the current financial metrics for Colgate-Palmolive, noting a market capitalization of $71.81 billion and a P/E ratio of 34.92. The stock recently opened at $89.74, trading between a 52-week low of $74.54 and a high of $99.33. Key balance sheet figures include a debt-to-equity ratio of 16.33 and liquidity ratios indicating current assets slightly exceed current liabilities. Analyst sentiment remains mixed with varying price targets, ranging from Wells Fargo's target of $92 to Deutsche Bank's objective of $99. The company maintains a quarterly dividend of $0.53 per share, payable on August 14th to shareholders of record on July 20th, resulting in an annualized yield of 2.4% and a payout ratio of 82.49%. Barclays recently raised its price target to $80 with an equal weight rating.